Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) tumors, including receptor tyrosine kinase (RTK)
inhibitors, PI3K/AKT/mTOR
inhibitors, RAF
Introduction: 3-ethoxythietane-1,1-dioxide (3ETD) is a
novel molecule that has demonstrated
the potential of stromal vascular fraction (SVF) cell therapy as a
novel regenerative treatment for ICH. SVF
and may present
novel opportunities for therapeutic intervention. This review aims to provide a